EAM
ASBP

Exos Asset Management’s Aspire Biopharma ASBP Stock Holding History

Exos Asset Management’s Portfolio ASBP Stock Details ASBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-125
Closed -$1.65M – 161
2024
Q1 		$1.65M Buy
+125
New +$1.64M 0.98% 54

Other funds holding ASBP

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Exos Asset Management's ASBP Position: Q2 2024 in Review

Exos Asset Management sold out of Aspire Biopharma (ASBP) in Q2 2024, closing a stake of 125 shares — an estimated $1.65M sold.

Exos Asset Management first reported a position in ASBP in Q1 2024 and held it in 1 quarter. The position peaked at $1.65M in Q1 2024. 3 funds tracked by Wall St. Rank hold ASBP as of Q2 2024.

  • Exos Asset Management reported no remaining Aspire Biopharma position as of Q2 2024 after selling out during the quarter.
  • Exos Asset Management sold 125 Aspire Biopharma shares in Q2 2024, an estimated $1.65M.
  • Exos Asset Management first reported a position in Aspire Biopharma in Q1 2024 and held it in 1 quarter.
  • Exos Asset Management's Aspire Biopharma position peaked at $1.65M in Q1 2024.
  • 3 funds tracked by Wall St. Rank held Aspire Biopharma as of Q2 2024.

Based on Exos Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.